Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Apple
AAPL
|
+$391M |
| 2 |
Amazon
AMZN
|
+$361M |
| 3 |
Microsoft
MSFT
|
+$358M |
| 4 |
Meta Platforms (Facebook)
META
|
+$196M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$171M |
Top Sells
| 1 |
Alibaba
BABA
|
+$1.07B |
| 2 |
Newmont
NEM
|
+$141M |
| 3 |
Eli Lilly
LLY
|
+$125M |
| 4 |
Waste Management
WM
|
+$124M |
| 5 |
McDonald's
MCD
|
+$112M |
Sector Composition
| 1 | Technology | 27.15% |
| 2 | Healthcare | 14.17% |
| 3 | Consumer Discretionary | 13.28% |
| 4 | Communication Services | 11.57% |
| 5 | Industrials | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Mesa Laboratories
MLAB
$327M
| $3.07M | ﹤0.01% |
11,302
+200
| +2% | +$54.2K |
|
1827
American Woodmark
AMWD
$950M
| $3.06M | ﹤0.01% |
37,500
+600
| +2% | +$49K |
|
1828
XPEL
XPEL
$990M
| $3.06M | ﹤0.01% |
36,500
+1,800
| +5% | +$151K |
|
1829
Extreme Networks
EXTR
$3.02B
| $3.05M | ﹤0.01% |
272,900
-8,200
| -3% | -$91.5K |
|
1830
Addus HomeCare
ADUS
$2.03B
| $3.04M | ﹤0.01% |
34,800
+500
| +1% | +$43.6K |
|
1831
Enterprise Financial Services Corp
EFSC
$2.27B
| $3.03M | ﹤0.01% |
65,364
-2,400
| -4% | -$111K |
|
|
PGTI
1832
DELISTED
PGT, Inc.
PGTI
| $3.02M | ﹤0.01% |
130,000
-4,800
| -4% | -$112K |
|
1833
James River Group
JRVR
$246M
| $3M | ﹤0.01% |
79,899
+9,900
| +14% | +$371K |
|
1834
Axcelis
ACLS
$2.62B
| $3M | ﹤0.01% |
74,100
-2,500
| -3% | -$101K |
|
1835
GoPro
GPRO
$316M
| $2.99M | ﹤0.01% |
256,800
-7,700
| -3% | -$89.7K |
|
1836
Cal-Maine
CALM
$5.38B
| $2.98M | ﹤0.01% |
82,400
-3,000
| -4% | -$109K |
|
|
RWT
1837
Redwood Trust
RWT
$802M
| $2.98M | ﹤0.01% |
247,100
-8,600
| -3% | -$104K |
|
1838
First Commonwealth Financial
FCF
$1.84B
| $2.98M | ﹤0.01% |
211,900
-7,700
| -4% | -$108K |
|
1839
Astec Industries
ASTE
$1.06B
| $2.98M | ﹤0.01% |
47,300
+800
| +2% | +$50.4K |
|
1840
Heron Therapeutics
HRTX
$196M
| $2.97M | ﹤0.01% |
191,400
-5,800
| -3% | -$90K |
|
1841
Fulgent Genetics
FLGT
$667M
| $2.96M | ﹤0.01% |
32,100
+1,600
| +5% | +$148K |
|
|
OCFT
1842
OneConnect Financial Technology
OCFT
$281M
| $2.95M | ﹤0.01% |
+24,562
| New | +$2.95M |
|
1843
Columbus McKinnon
CMCO
$417M
| $2.95M | ﹤0.01% |
61,111
+6,500
| +12% | +$314K |
|
1844
Stride
LRN
$6.89B
| $2.94M | ﹤0.01% |
91,600
-3,300
| -3% | -$106K |
|
1845
Utz Brands
UTZ
$1.12B
| $2.94M | ﹤0.01% |
134,900
+33,100
| +33% | +$721K |
|
|
SWI
1846
DELISTED
SolarWinds Corporation Common Stock
SWI
| $2.94M | ﹤0.01% |
164,857
+28,819
| +21% | +$513K |
|
|
BRMK
1847
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
| $2.93M | ﹤0.01% |
276,900
-10,100
| -4% | -$107K |
|
1848
Aurinia Pharmaceuticals
AUPH
$1.68B
| $2.93M | ﹤0.01% |
225,500
-20,400
| -8% | -$265K |
|
|
ALEX
1849
Alexander & Baldwin
ALEX
$1.36B
| $2.92M | ﹤0.01% |
159,620
+2,600
| +2% | +$47.6K |
|
1850
Celldex Therapeutics
CLDX
$1.67B
| $2.92M | ﹤0.01% |
87,200
-3,200
| -4% | -$107K |
|